Cardiogen at BIO-EUROPE 2025

Munich, September 22, 2025 – Cardiogen GmbH, a preclinical clinical life science company focusing on cardiovascular regeneration and cellular reprogramming, is participating in the BIO-EUROPE Conference 2025.

The conference is an international forum to promote business development between pharmaceutical, financial and biotechnology companies. The event is Europe's largest partnering conference serving the global biotech industry. At this conference leading decision makers of the biotechnology, pharmaceutical and financial industry employed at emerging companies meet annually.

Cardiogen is presenting its technology and clinical therapy program for cardiovascular diseases.

BIO-EUROPE is taking place from November 3 to 5, 2025 in Vienna, Austria.

About Cardiogen

Cardiogen’s non-invasive regenerative approach can potentially play a significant role in improving the survival rate and quality of life for patients who experience a heart attack, as well as in various other cardiovascular diseases. 

For more information, visit: https://www.cardiogentx.com/ or contact info@cardiogentx.com